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a  b  s  t  r  a  c  t
Aim: The aim of this study was to determine the Inflection Points (IPs) of flattening fil-
ter  free (FFF) CyberKnife dose profiles for cone-based streotactic radiotherapy. In addition,
dosimetric field sizes were determined.
Background: The increased need for treatment in the early stages of cancer necessitated
the treatment of smaller tumors. However, efforts in that direction required the modeling
accuracy of the beam. Removal of the flattening filter (FF) from the path of x-ray beam has
provided the solution to those efforts, but required a different normalization approach for
the beam to ensure the delivery of the dose accurately. As a solution, researchers proposed
a  normalization factor based on IPs.
Materials and methods: Measurements using microDiamond (PTW 60019), Diode SRS (PTW
60018) and Monte Carlo (MC) calculations of dose profiles were completed at SAD 80 cm
and 5 cm depth for 15–60 mm cones. Performance analysis of detectors with respect to MC
calculation was carried out. Gamma evaluation method was used to determine achievable
acceptability criteria for FFF CyberKnife beams.
Results: Acceptability within (3%–0.5 mm) was found to be anachievable criterion for all dose
profile measurements of the cone beams used in this study. To determine the IP, the first
and second derivatives of the dose profile were determined via the cubic spline interpolationtechnique.
Conclusion: Derivatives of the interpolated profiles showed that locations of IPs and 50%
isodose points coincide.
© 2019 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.∗ Corresponding author.
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Yeğiner),  hakyol@hacettepe.edu.tr (F. Akyol), utku@hacettepe.edu.tr (H
https://doi.org/10.1016/j.rpor.2019.10.008
1507-1367/© 2019 Greater Poland Cancer Centre. Published by Elsevier kci@hacettepe.edu.tr (F.Y. Yedekçi), yeginer@hacettepe.edu.tr (M.
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reports of practical oncology a
.  Aim
his study aimed to analyze the CyberKnife dose profile for the
ocation of IPs and to determine the appropriate normalization
rocedure to ensure that the recommended dose is delivered
orrectly.
.  Background
edical Physicists define the IP of a dose profile curve as
he point of the curve where progression of dose deposition
hanges direction geometrically from positive to negative or
ice versa. Because at that point, the normal vector to the pro-
le curve changes its direction from one side to the opposite;
he curve crosses its tangent line at IP.
Historically, significance of the IP of a dose profile stems
rom the fact that the dose characteristics of linear accelera-
ors (linacs) without a flattening filter are very different from
hose of linacs with an FF. While FFs produce a uniform inten-
ity across the field, the FFF dose profile is not uniform but
eaked.1 Physical and dosimetric differences between flat-
ened and unflattened dose profile raised concerns about the
onventional normalization applied to the dose profiles of
nflattened beams. In order to allow dose profiles from FFF
eam to be realistically compared to dose profiles from FF
eams, a normalization factor based on IP was proposed by
önisch et al.2 They introduced a normalization factor for the
arian Clinac 21EX system, defined as the ratio of the dose at
he IP of the penumbral region of the unflattened profile to
he dose at the IP of the flattened profile, multiplied by the
ose value at the central axis of the flat profile. Renormaliza-
ion allowed them to evaluate the field size at IPs, or at 50%
ose level to keep the common dosimetric field size defini-
ion. Mesbahi et al.3 calculated the dosimetric features of an
nflattened 6-MV photon beam of an Elekta SL-25 linac using
he Monte Carlo (MC) method. They employed the method of
önisch et al. for penumbra comparisons between flattened
nd unflattened cases, and used some features of beam pro-
les, such as the penumbra between off-axis doses of 80% and
0% and the location of the field edge at an off-axis dose of
0%. Sinha et al.4 investigated the penumbra of a 6-MV flat-
ened beam and a 7-MV unflattened beam of a Siemens Artiste
inac using the IP method. Pichandi et al.5 aimed to analyze
hysical parameters of FFF beams and determined the IP for
tandardizing beam flatness and penumbra for Varian True
eam system. They defined the radiation (dosimetric) field size
s the lateral separation between IPs along the central axis
nd proposed a method to find its location. In a more  recent
tudy, dimensions of radiation fields delivered by eight dosi-
etrically matched Varian iX linacs were determined.6 In their
onclusion, emphasis was put on the difficulty and impor-
ance of maintaining radiation field size consistency between
matched” linacs.
The above-mentioned analyses of FFF beams were based
n the establishment of a relationship between standard FF
nd FFF beams. Relationship applies mainly to linacs that
ave both the standard FF and FFF beams. On the other hand,
he CyberKnife system does not use an FF beam. Therefore,diotherapy 2 5 ( 2 0 2 0 ) 6–12 7
validity of IP definition for the field size has to be investigated
for the CyberKnife system. It is known that accurate measure-
ments of dose distributions play an indispensable role in the
success of field size determination. Importance of accurately
measuring and reporting field sizes was emphasized by sev-
eral authors.6–8 One way to evaluate the dosimetric accuracy
is to compare detector measurements and to compare them
with MC simulation. In this study, as part of quality assurance,
we first used the gamma evaluation method to quantitatively
compare dose profiles measured with different detectors and
with reference MC calculated profiles. The comparison was
performed using different acceptability criteria. Finally, the
location of IPs on dose profiles of the CyberKnife system and
dosimetric field sizes was determined.
3.  Materials  and  methods
3.1.  Detectors
We  used two real-time detectors: a microDiamond (PTW
60019, PTW, Freiburg, Germany) and a diode SRS detector
(PTW 60018). The microDiamond detector had a 1 m-thick,
1.1 mm-radius circular active layer and a sensitive volume of
0.004 mm3. The disk-shaped Diode SRS detector had a radius
of 0.6 mm and a sensitive volume of 0.3 mm3. These detectors
have a high spatial resolution, a small and stable background,
and fast acquisition. Both are useful when small-step mea-
surements in a high-gradient region are needed.
3.2.  Irradiation  procedure
The CyberKnife system uses interchangeable circular sec-
ondary collimators, the field sizes of which are defined under
an isocentric setup. All irradiations were performed using
CyberKnife 6 MV  with various collimation sizes from 15 mm
to 60 mm.  The microDiamond and Diode SRS detectors were
placed in a water tank. The measurement step between each
point for all cone sizes was 0.2 mm.  Beam profiles for all colli-
mators were measured at a depth of 5 cm with Source-to-Axis
Distance (SAD) of 80 cm.  All profiles were normalized to a
maximum dose in the central axis at a depth of 5 cm.  Dose
measurements at 200 MU/measurement were repeated three
times.
3.3.  EGSnrc  Monte  Carlo  simulations
Monte Carlo techniques are widely accepted as the gold
standard for radiation transport simulation in radia-
tion therapy.9,10 Dose profiles were calculated using
EGSnrc/BEAMnrc Monte Carlo code11,12 in conjunction
with the DOSXYZnrc code. Phase space files for 15, 20 30, and
60 mm cones were generated using a model of the treatment
head of the CyberKnife SRS system13 and the phase space
data were stored below the secondary collimator. The histo-
ries of 3 × 108 electrons incident on the target were simulated.
The mean energy of the incident electrons and the full width
at half-maximum (FWHM) of the electron radial intensity
distribution were 6.7 MeV and 3.2 mm,  respectively.13 The
global electron and photon cut-off energies (ECUT and PCUT)
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Fig. 1 – Beam profiles corresponding to 15, 20, 30 and 60 mm cone sizes. The blue square for MC,  green and red lines are for
Diode SRS and microDiamond, respectively.
for particle transport were set to 700 keV (total energy) and
10 keV, respectively. The phase space data were used as a
source for DOSXYZnrc. The MC  simulation was validated
through percentage depth dose (PDD) and output factors
measurements and results were published elsewhere.14
For MC  dose profiles the water phantom was modelled as
30 cm × 30 cm × 30 cm using different voxel sizes, 1 mm for all
cone sizes except 60 mm cone for which it was 5 mm.  The
dose profile computation was at the depth of 5 cm with SAD of
80 cm.  With these specifications, 1 × 107–3 × 108 histories were
needed to achieve a statistical uncertainty less than 1%.
3.4.  Gamma  evaluation  method
To establish an acceptance criterion between differ-
ent dosimeter readings, gamma  index of the evaluation
method,15,16  (rr, rm), was used to quantitatively compare
reference (MC  calculated) and measured dose profiles:




∣∣D (rm) − D (rr)∣∣2
D2
(1)
where r is the predetermined spatial difference (distance-to-
agreement) between the dose point rm in the measured dose
distribution and the nearest point rr in the reference dose dis-
tribution containing the same dose value; D (rr) and D (rm) are
doses at reference and measured locations, respectively; and
D is the predetermined dose difference at those locations.
Gamma  evaluation takes into account acceptability of both the
percentage dose (D%) and the spatial difference (r in mm)
to compare two different dose distributions. The comparison
passes if  ≤ 1.4.  Results
Dose profiles from data measured with a microDiamond
detector, a Diode SRS detector and those calculated using the
MC simulation are shown in Fig. 1. For smaller cones, the dose
distribution had a steeper decline in the penumbral region,
which shows that the measurements need to be made in small
steps. This requires the use of dosimeters with small sen-
sitive volumes because a small change in the position of a
detector in the penumbral region results in a large difference
in dose readings. For all cone sizes, the differences in detec-
tor measurements were <2% in the central and penumbral
regions.
Gamma  evaluation was applied to measurements from all
detectors and the MC calculation, for all cone sizes, and the
results were compared. The acceptability criteria define the
permissible range of variation in acceptability based on clin-
ical requirements and measurement limitations. In Fig. 2a–c,
gamma  indexes are presented for the 15 mm cone. Shown
values serve as a measure of disagreement or agreement
in the locations that fail or pass the acceptability criteria,
respectively. For three chosen acceptability criteria based on
previously gained experience,17 Fig. 2a shows the distribu-
tion of gamma indexes to determine locational agreements
between Diode SRS measurements and the reference dose dis-
tributions which was calculated by EGSnrc software tool using
MC method. In Fig. 2b, locational agreements are shown for
microDiamond measurements and MC.  Comparison of mea-
surements with MC computed doses via gamma evaluation
method with criterion of (3%, 0.5 mm)  are in good agreement
at all locations. When comparison is made between Diode SRS
and microDiamond as shown in Fig. 2c, we  observe similar
results. Values of gamma index with acceptance criteria of
either (1%, 1 mm)  or (2%, 0.2 mm)  were greater or equal to 1
( ≥ 1) within the region where dose ratios were in the range
reports of practical oncology and radiotherapy 2 5 ( 2 0 2 0 ) 6–12 9
Fig. 2 – Gamma  values for three different sets of tolerance criteria (3%–0.5, 1%–1, 2%–0.2). Comparison test for (a) Diode SRS































Table 1 – Dosimetric field sizes (FWHM) obtained by
detectors and MC  computation.
Dosimetric field size (mm)
Cone Size (mm) PTW 60019 PTW 60018 MC
60 61.3 61.3 61.4
differences in the filed size determinations. In Table 1, the low-iode SRS.
f 10 to 90% across the dose profile. (3%, 0.5 mm)  criterion was
atisfied at all locations.
Several authors18,19 have already emphasized the impor-
ance of measurements with fine steps and the use of smaller
etectors within the penumbra region. In Eq. (1), the vari-
bles rr and rm are controllable because they are adjustable in
C calculations and measurements, respectively. Using the
mallest step to advance a detector within the penumbral
egion yields the smallest difference between two successive
ose measurements. This should allow tighter acceptance
riteria. However, Fig. 2 shows that even when the small-
st step size (0.2 mm)  was used in the experiment, the
cceptance criteria of (2%, 0.2 mm)  did not yield  ≤ 1 at
ost locations. The combination of 3% dose difference crite-
ion and 3 mm spatial difference (the distance-to-agreement)
riterion is commonly used as the acceptability criteria
or the gamma evaluation method.17,20 In this study, the
amma index criterion  ≤ 1 can be satisfied throughout
he profile when the dose difference and the distance-to-
greement criteria are set to 3% and 0.5 mm,  respectively.
or the 6 MV  photon beam of the CyberKnife, the distance
etween the 20% and 80% isodoses in the penumbral is about
3 mm at a phantom depth of 5 cm.  Therefore, the level of
ncertainty involved in determining the field edge and the
osimetric accuracy introduced as a result can easily be ascer-
ained.
Since the CyberKnife system does not use an FF, the stan-
ardization procedure of LINAC systems working both with
nd without FF is not applicable. We used the cubic spline
nterpolation technique to locate the IPs. Because the IP is the
ocation where the second derivative of a function describing30 30.5 30.6 30.6
20 20.3 20.3 20.4
15 15.1 14.6 15.4
the dose profile is zero, the first and second derivatives of the
dose profiles were determined using the profiles interpolated
from the step by step measurements for the diamond and
diode detectors. Fig. 3 shows the dose profiles measured using
microDiamond detector and their first and second derivatives
for the 15 and 60 mm cones. For all the cones in this study,
the maximum of first derivatives of dose profiles are at the
50% isodose points and values of second derivatives are zero
at those locations. The first and second derivative plots show
that the 50% dose points coincide with the IP of the profile.
This result holds for all fields examined in this study.
Table 1 gives the dosimetric field sizes determined at
a phantom depth of 5 cm by each detector for each cone
size. The voxel size for the calculated dose distributions
was approximately the same as the sensitive size of both
SRS diode and microDiamond detectors. This is important
in order to make the measurements consistent with calcu-
lations. Depending on the type of detector used, there may beest relative difference between the dosimetric and geometric
field size is 0.7% for the 15 mm cone from the microdiamond
measurement.
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Fig. 3 – Column on the left shows the dose profile using microdiamond (a) for 15 mm cone, and its first and second derivate
.obtained by interpolation right column is (b) for 60 mm cone
5.  Discussion
In this work, the microDiamond detector, the Diode SRS detec-
tor and EGSnrc Monte Carlo model for CyberKnife SRS System
were used to measure off-axis profiles of 1560 mm diameter
radiosurgical beams of a CyberKnife robotic SRS system. Dose
profiles were then compared using the gamma  index  (rr, rm)
of the evaluation method given by Eq. (1). Results of MC  dose
calculations were used as reference in the evaluation of the
gamma index. In general, a standard MC  dose calculation
accuracy better than 2% is considered acceptable. In our case,
MC history was chosen to achieve a statistical uncertainty less
than 1%.
The gamma evaluation method is a combination between
the dose difference and the distance-to-agreement evaluation
methods. Our calculations showed that although we obtained
less than 2% difference in detector measurements, a looser
criterion on the dose difference should be selected to pass the
comparison test with the MC  calculation. It is important to
evaluate both the spatial difference and the dose difference
to satisfy requirements on both geometrical and dosimetrical
precision together.Referred publications in the Introduction section classify
unflattened profiles based on the IPs rather than the conven-
tional full width half maximum (FWHM, 50% dose level). In the
CyberKnife system, the nominal field size for the FFF beamis defined by a collimator setting. In general, variation in a
profile is measured along two orthogonal axes (in 2D measure-
ments) within the field and the maximum variation is defined.
Therefore, Pichandi et al.5 have defined dosimetric field size
for FFF beams through lateral separation between IPs along the
central axis. When characteristics of a beam is such that the
50% dose edges and IPs are at the same location on the beam
profile, two outcomes become apparent. First, normalization
using the dose at inflection points or the re-normalization pro-
cedure described by Fogliata et al.18 is not necessary. Secondly,
the linac system in operation can locate the maximum varia-
tion in the profile much faster, making it easier to determine
the variation along the two orthogonal axes.
For all cone sizes, we found that first derivatives have peaks
at the location of 50% dose edge. Second derivative curves
change their signs while passing through the 50% dose edge
and the value of second derivative functions are zero at that
point. In Fig. 3, we present the results for the largest and the
smallest cones. It can be seen from the figure that the IP in
the unflattened profile and the 50% dose edge are at the same
locations. Beam characterization involves measurement of the
dose profile and the dose profile analysis allows to understand
the beam’s characteristics. The location of IPs on a dose pro-
file is one of the beam properties that remains unchanged for
a given linac, regardless of which cone size is used to deliver
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n profiles, it is sufficient to determine its locations between
0 mm and 15 mm cones.
According to the vendor’s specification, both SRS diode
nd the microdiamond are well suited for measurements
n small fields less than 1 cm × 1 cm.  Their length is exactly
he same. Both are non-shielded and do not show a vol-
me  effect. Volume effect is especially important because
t causes penumbra broadening (FWHM). SRS diode cross
ection in the beam is slightly smaller than for the microdi-
mond detector. The water-equivalent window thickness of
he microdiamond is smaller; however, the difference between
heir correction factors we  obtained for another study was
ot significant.14 In this work, measured values for field sizes
ere the same except for the 15 mm cone. For the smallest
one, there is a direction of difference between these two
valuations. This may be attributed to the decrease in the
ensitivity of SRS diode when the contribution of the scat-
ered photons to the absorbed dose becomes lower as the field
ize becomes smaller. In summary, the microDiamond and
iode SRS showed similar performance for 20–60 mm cones.
or 15 mm cone, however, the microDiamond had a reasonably
etter performance.
.  Conclusion
n this study, a comparative test for acceptability of dose pro-
le measurements using different detectors was made with
espect to EGSnrc Monte Carlo calculation. Analysis by the
amma evaluation method showed that detector measure-
ents were acceptable within (3%, 0.5 mm)  dose and distance
ntervals, respectively.
In some studies,2–5 radiation field size of FFF beam was
efined through lateral separation between IPs along the cen-
ral axis. In order to determine dosimetric field sizes, we also
nvestigated the location of IPs on dose profiles. We  revealed
hat the 50% isodose and the IPs are at the same location on
he dose profile of 6 MeV  CyberKnife system. This evaluation
as done with the interpolation of the measured dose profile.
ocation of IP were determined by the first and second deriva-
ive methods. Measurements were carried out using very small
easurement steps and the detectors are carefully positioned
n order to attain the highest accuracy.
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